X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hyper-cvad (357) 357
humans (277) 277
index medicus (241) 241
hematology (217) 217
oncology (210) 210
adult (202) 202
male (187) 187
female (184) 184
middle aged (179) 179
chemotherapy (144) 144
aged (140) 140
antineoplastic combined chemotherapy protocols - therapeutic use (116) 116
treatment outcome (115) 115
acute lymphoblastic leukemia (112) 112
acute lymphocytic-leukemia (112) 112
cancer (110) 110
adolescent (99) 99
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (97) 97
rituximab (88) 88
remission induction (82) 82
acute lymphocytic leukemia (80) 80
therapy (76) 76
minimal residual disease (75) 75
prognosis (74) 74
transplantation (73) 73
precursor cell lymphoblastic leukemia-lymphoma - therapy (72) 72
young adult (71) 71
precursor cell lymphoblastic leukemia-lymphoma - mortality (69) 69
disease-free survival (65) 65
leukemia (62) 62
philadelphia chromosome (62) 62
stem-cell transplantation (60) 60
term-follow-up (57) 57
vincristine - administration & dosage (57) 57
acute lymphoblastic-leukemia (56) 56
adult patients (56) 56
cyclophosphamide - administration & dosage (54) 54
imatinib (54) 54
care and treatment (52) 52
mantle cell lymphoma (51) 51
doxorubicin - administration & dosage (50) 50
regimen (50) 50
antineoplastic agents - therapeutic use (49) 49
antineoplastic combined chemotherapy protocols - administration & dosage (49) 49
phase-ii (49) 49
survival (48) 48
hematopoietic stem cell transplantation (47) 47
retrospective studies (47) 47
survival analysis (47) 47
precursor cell lymphoblastic leukemia-lymphoma - genetics (46) 46
survival rate (45) 45
dexamethasone - administration & dosage (44) 44
aged, 80 and over (42) 42
cytarabine - administration & dosage (41) 41
abridged index medicus (39) 39
precursor cell lymphoblastic leukemia-lymphoma - pathology (38) 38
analysis (37) 37
non-hodgkins-lymphoma (37) 37
antineoplastic combined chemotherapy protocols - adverse effects (36) 36
transplantation, homologous (36) 36
inotuzumab ozogamicin (35) 35
progression-free survival (35) 35
article (34) 34
dose-intensive regimen (34) 34
lymphomas (34) 34
stem cells (34) 34
trial (34) 34
children (33) 33
recurrence (33) 33
research (33) 33
vincristine (33) 33
cyclophosphamide (32) 32
medicine & public health (32) 32
dasatinib (31) 31
follow-up studies (31) 31
hematology, oncology and palliative medicine (31) 31
remission (31) 31
stem cell transplantation (31) 31
lymphoma, mantle-cell - drug therapy (30) 30
methotrexate - administration & dosage (29) 29
acute lymphatic leukemia (28) 28
combined modality therapy (28) 28
risk factors (28) 28
salvage therapy (28) 28
chronic myeloid-leukemia (27) 27
clinical trials (26) 26
doxorubicin (26) 26
hematopoietic stem cells (26) 26
hemic and lymphatic diseases (26) 26
imatinib mesylate (26) 26
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (26) 26
vincristine - therapeutic use (26) 26
adults (25) 25
age factors (25) 25
bone-marrow-transplantation (25) 25
drug administration schedule (25) 25
group-b (25) 25
lymphoma (25) 25
patients (25) 25
protein kinase inhibitors - therapeutic use (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (381) 381
Russian (5) 5
French (2) 2
Japanese (2) 2
Chinese (1) 1
Korean (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 04/2019, Volume 133, Issue 14, pp. 1548 - 1559
Retrospective studies have suggested that older adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) have better survival rates when... 
ALLOGENEIC TRANSPLANTATION | HYPER-CVAD | CONSOLIDATION | PROTOCOLS | KINASE | OUTCOMES | GROUP-B | HEMATOLOGY | REMISSION INDUCTION | CANCER | CHEMOTHERAPY
Journal Article
JOURNAL OF IMMUNOLOGY, ISSN 0022-1767, 02/2015, Volume 194, Issue 3, pp. 911 - 920
The effectiveness of chimeric Ag receptor (CAR)-transduced T (CAR-T) cells has been attributed to supraphysiological signaling through CARs. Second-and... 
DEPENDENT CELLULAR CYTOTOXICITY | CD20 PROTEIN EXPRESSION | HYPER-CVAD | THERAPY | AFFINITY | RITUXIMAB | ACUTE LYMPHOBLASTIC-LEUKEMIA | CHRONIC LYMPHOCYTIC-LEUKEMIA | LYMPHOMA | TUMOR-CELLS | IMMUNOLOGY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 9, pp. 836 - 847
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2018, Volume 36, Issue 35, pp. 3504 - 3519
Traditional treatment regimens for adult acute lymphoblastic leukemia, including allogeneic hematopoietic cell transplantation, result in an overall survival... 
YOUNG-ADULTS | HYPER-CVAD | ONCOLOGY | INOTUZUMAB OZOGAMICIN | TERM-FOLLOW-UP | PHASE-II | RELAPSE-FREE SURVIVAL | STEM-CELL TRANSPLANTATION | SINGLE-ARM | MINIMAL RESIDUAL DISEASE | MURINE XENOGRAFT MODELS
Journal Article
Journal Article
AMERICAN JOURNAL OF HEMATOLOGY, ISSN 0361-8609, 03/2017, Volume 92, Issue 3, pp. 238 - 243
In patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) treated with chemotherapy plus a tyrosine kinase inhibitor (TKI),... 
SURVIVAL | ADULT PATIENTS | CYTOGENETIC ABERRATIONS | DIAGNOSIS | HYPER-CVAD | IMPACT | ABNORMALITIES | IMATINIB | TERM-FOLLOW-UP | HEMATOLOGY
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4, pp. 394 - 401
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 4, pp. 403 - 411
Journal Article
Blood, ISSN 0006-4971, 04/2007, Volume 109, Issue 8, pp. 3189 - 3197
Journal Article
Blood, ISSN 0006-4971, 01/2019, Volume 133, Issue 2, pp. 130 - 136
The introduction of agents targeted at specific molecular events is changing the treatment paradigms in a number of malignancies. Historically, we have relied... 
CHRONIC MYELOGENOUS LEUKEMIA | ADULT PATIENTS | ALLOGENEIC TRANSPLANTATION | INTENSITY CHEMOTHERAPY | HYPER-CVAD | CHEMOTHERAPY PLUS DASATINIB | ABL TYROSINE KINASE | TERM-FOLLOW-UP | PHASE-II | STEM-CELL TRANSPLANTATION | HEMATOLOGY
Journal Article
Blood cancer journal, ISSN 2044-5385, 06/2017, Volume 7, Issue 6, pp. e577 - e577
Journal Article